chr11-71444125-C-T

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The ENST00000355527.8(DHCR7):​c.189G>A​(p.Gln63=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.678 in 1,610,010 control chromosomes in the GnomAD database, including 392,378 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.58 ( 27496 hom., cov: 33)
Exomes 𝑓: 0.69 ( 364882 hom. )

Consequence

DHCR7
ENST00000355527.8 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: 3.07
Variant links:
Genes affected
DHCR7 (HGNC:2860): (7-dehydrocholesterol reductase) This gene encodes an enzyme that removes the C(7-8) double bond in the B ring of sterols and catalyzes the conversion of 7-dehydrocholesterol to cholesterol. This gene is ubiquitously expressed and its transmembrane protein localizes to the endoplasmic reticulum membrane and nuclear outer membrane. Mutations in this gene cause Smith-Lemli-Opitz syndrome (SLOS); a syndrome that is metabolically characterized by reduced serum cholesterol levels and elevated serum 7-dehydrocholesterol levels and phenotypically characterized by cognitive disability, facial dysmorphism, syndactyly of second and third toes, and holoprosencephaly in severe cases to minimal physical abnormalities and near-normal intelligence in mild cases. Alternative splicing results in multiple transcript variants that encode the same protein.[provided by RefSeq, Aug 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.44).
BP6
Variant 11-71444125-C-T is Benign according to our data. Variant chr11-71444125-C-T is described in ClinVar as [Benign]. Clinvar id is 93713.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-71444125-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=3.07 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.73 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
DHCR7NM_001360.3 linkuse as main transcriptc.189G>A p.Gln63= synonymous_variant 4/9 ENST00000355527.8 NP_001351.2
DHCR7NM_001163817.2 linkuse as main transcriptc.189G>A p.Gln63= synonymous_variant 4/9 NP_001157289.1
DHCR7XM_011544777.3 linkuse as main transcriptc.189G>A p.Gln63= synonymous_variant 4/9 XP_011543079.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
DHCR7ENST00000355527.8 linkuse as main transcriptc.189G>A p.Gln63= synonymous_variant 4/91 NM_001360.3 ENSP00000347717 P1

Frequencies

GnomAD3 genomes
AF:
0.578
AC:
87821
AN:
151986
Hom.:
27466
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.403
Gnomad AMI
AF:
0.674
Gnomad AMR
AF:
0.536
Gnomad ASJ
AF:
0.616
Gnomad EAS
AF:
0.365
Gnomad SAS
AF:
0.201
Gnomad FIN
AF:
0.569
Gnomad MID
AF:
0.458
Gnomad NFE
AF:
0.736
Gnomad OTH
AF:
0.554
GnomAD3 exomes
AF:
0.565
AC:
137936
AN:
243970
Hom.:
42951
AF XY:
0.558
AC XY:
73683
AN XY:
131994
show subpopulations
Gnomad AFR exome
AF:
0.395
Gnomad AMR exome
AF:
0.539
Gnomad ASJ exome
AF:
0.625
Gnomad EAS exome
AF:
0.372
Gnomad SAS exome
AF:
0.209
Gnomad FIN exome
AF:
0.580
Gnomad NFE exome
AF:
0.716
Gnomad OTH exome
AF:
0.601
GnomAD4 exome
AF:
0.688
AC:
1002927
AN:
1457908
Hom.:
364882
Cov.:
53
AF XY:
0.674
AC XY:
488636
AN XY:
724926
show subpopulations
Gnomad4 AFR exome
AF:
0.373
Gnomad4 AMR exome
AF:
0.539
Gnomad4 ASJ exome
AF:
0.626
Gnomad4 EAS exome
AF:
0.333
Gnomad4 SAS exome
AF:
0.215
Gnomad4 FIN exome
AF:
0.587
Gnomad4 NFE exome
AF:
0.763
Gnomad4 OTH exome
AF:
0.635
GnomAD4 genome
AF:
0.578
AC:
87896
AN:
152102
Hom.:
27496
Cov.:
33
AF XY:
0.562
AC XY:
41785
AN XY:
74340
show subpopulations
Gnomad4 AFR
AF:
0.404
Gnomad4 AMR
AF:
0.536
Gnomad4 ASJ
AF:
0.616
Gnomad4 EAS
AF:
0.365
Gnomad4 SAS
AF:
0.203
Gnomad4 FIN
AF:
0.569
Gnomad4 NFE
AF:
0.736
Gnomad4 OTH
AF:
0.548
Alfa
AF:
0.676
Hom.:
18521
Bravo
AF:
0.578
Asia WGS
AF:
0.265
AC:
925
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:13
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Smith-Lemli-Opitz syndrome Benign:6
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesOct 05, 2021- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 01, 2021- -
Benign, no assertion criteria providedclinical testingNatera, Inc.Aug 09, 2017- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsMay 08, 2017- -
not specified Benign:4
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jun 06, 2018- -
not provided Benign:2
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingGeneDxMar 03, 2015- -
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsMar 11, 2016This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.44
CADD
Benign
13
DANN
Benign
0.84

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.19
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1044482; hg19: chr11-71155171; COSMIC: COSV62794719; COSMIC: COSV62794719; API